Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · IEX Real-Time Price · USD
4.160
+0.105 (2.59%)
At close: Jul 19, 2024, 4:30 PM
4.100
-0.060 (-1.44%)
Pre-market: Jul 22, 2024, 4:10 AM EDT
Relmada Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for RLMD stock has a target of 2.00, which predicts a decrease of -51.92% from the current stock price of 4.16.
Analyst Consensus: Strong Sell
* Price targets were last updated on Jun 5, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for RLMD is "Strong Sell". This means that the analyst believes this stock is likely to have very poor returns in the near future.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Total | 5 | 5 | 5 | 5 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold → Strong Sell Downgrades $3 → $2 | Hold → Strong Sell | Downgrades | $3 → $2 | -51.92% | Jun 5, 2024 |
| Mizuho | Mizuho | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +525.00% | Jun 15, 2023 |
| SVB Leerink | SVB Leerink | Buy Maintains $42 → $10 | Buy | Maintains | $42 → $10 | +140.38% | Jan 23, 2023 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $8 | Strong Buy → Hold | Downgrades | $8 | +92.31% | Oct 14, 2022 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 14, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.07
from -3.28
EPS Next Year
-2.63
from -3.07
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 105.0M | 201.2M | 409.4M |
| Avg | n/a | n/a | 32.9M | 111.3M | 295.4M |
| Low | n/a | n/a | n/a | 26.1M | 185.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 511.6% | 267.9% |
| Avg | - | - | - | 238.3% | 165.5% |
| Low | - | - | - | -20.8% | 66.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.98 | -1.52 | -1.16 | -0.70 | 1.68 |
| Avg | -3.07 | -2.63 | -2.48 | -0.68 | 1.63 |
| Low | -3.16 | -4.33 | -3.80 | -0.66 | 1.57 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.